Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Vascular Involvement in Behçet's Disease
NCT04328064Completed
- Sponsor
- Alexandria University
- Start
- May 2010
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial in Behçet's disease (BD) comparing Rosuvastatin Drug with Placebo drug (2 arms). Primary endpoint: Changes in endothelial and vascular inflammatory markers at 12 months. Started May 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT04328064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328064.